DNTH
DNTH clinical trials: Dianthus Therapeutics, Inc. /DE/
Every trial on ClinicalTrials.gov where Dianthus Therapeutics, Inc. /DE/ is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
DNTH on the catalyst calendar · DNTH registry changes
- Primary completion Dec 2028Sponsor estimatePhase 3NCT07647510A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)Dianthus Therapeutics · Myasthenia Gravis, GeneralizedRecruitingDNTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2028Sponsor estimatePhase 3NCT06858579A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)Dianthus Therapeutics · Chronic Inflammatory Demyelinating PolyneuropathyRecruitingDNTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 2NCT06537999A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor NeuropathyDianthus Therapeutics · Multifocal Motor NeuropathyActive, not recruitingDNTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 28, 2025ActualPhase 2NCT06282159A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)Dianthus Therapeutics · Myasthenia Gravis, GeneralizedActive, not recruitingDNTHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner